Literature DB >> 14985959

Perforation of the colon after administration of neostigmine.

R Mollema, J Jaap Spijkstra, K H Polderman, H P M M Gelissen, A R J Girbes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985959     DOI: 10.1007/s00134-004-2178-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Treatment of acute colonic pseudo-obstruction with neostigmine.

Authors:  H Paran; D Silverberg; A Mayo; I Shwartz; D Neufeld; U Freund
Journal:  J Am Coll Surg       Date:  2000-03       Impact factor: 6.113

2.  Pathophysiology of adynamic ileus.

Authors:  J J Cullen; D K Caropreso; L L Hemann; M Hinkhouse; J L Conklin; K S Ephgrave
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

3.  Neostigmine for the treatment of acute colonic pseudo-obstruction.

Authors:  R J Ponec; M D Saunders; M B Kimmey
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

Review 4.  Gastrointestinal tract dysfunction in critical illness: pathophysiology and interaction with acute lung injury in adult respiratory distress syndrome/multiple organ dysfunction syndrome.

Authors:  E D Crouser; P M Dorinsky
Journal:  New Horiz       Date:  1994-11

5.  Acute colonic pseudo-obstruction: a pharmacological approach.

Authors:  R Hutchinson; C Griffiths
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

  5 in total
  2 in total

Review 1.  COVID 19 and the risk of gastro-intestinal perforation: A case series and literature review.

Authors:  Joris Paul Bulte; Nynke Postma; Menno Beukema; Bas Inberg; Abe Gerrit Stegeman; Hans van der Hoeven
Journal:  J Crit Care       Date:  2021-11-02       Impact factor: 3.425

2.  Colonic perforation associated with neostigmine administration.

Authors:  Christopher R McDonald; Darren Tonkin; Peter Hewett
Journal:  J Surg Case Rep       Date:  2013-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.